Rare Diseases

Rare cancers encompass a diverse group of malignancies that individually affect a limited number of patients. These diseases, while individually rare, collectively impact a significant portion of the population. 

Current treatments often face challenges due to limited research and understanding, resulting in a lack of standardized therapeutic approaches. However, recent advancements in oncology have sparked a renewed focus on these less common malignancies. Precision medicine, immunotherapies, and targeted therapies are emerging as promising avenues, tailoring treatments to the specific genetic and molecular characteristics of each rare cancer.

Expert video highlights and insights from the conference hub and comprehensive peer-reviewed articles from our journal portfolio provide updates on the changing treatment landscape. To learn more about how the latest developments impact on patient outcomes view our expert-led learning activities.

Our supporting partners do not constitute an endorsement of the content on this page.